Inventor · disambiguated record
Mustafa Demirbüker
Also filed as: DEMIRBUEKER MUSTAFA · DEMIRBUKER MUSTAFA · DEMIRBÜKER MUSTAFA
25 granted patents·4 pending applications·474 citations·filing 1999–2024
97Inventor score
Files withXSPRAY MICROPARTICLES AB14XSPRAY PHARMA AB8ASTRAZENECA AB4DEMIRBUEKER MUSTAFA2CERBIOS PHARMA SA1
Top patents by PatentIndex Score
29 records- 0198US11241419B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2020·Granted Feb 8, 2022·7 cites·24 claims
- 0298US10772877B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2020·Granted Sep 15, 2020·21 cites·30 claims
- 0398US10314830B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2018·Granted Jun 11, 2019·38 cites·30 claims
- 0498US10143683B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2017·Granted Dec 4, 2018·39 cites·30 claims
- 0598US9833442B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2017·Granted Dec 5, 2017·41 cites·23 claims
- 0698US9833443B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2017·Granted Dec 5, 2017·34 cites·23 claims
- 0798US9827230B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2016·Granted Nov 28, 2017·41 cites·23 claims
- 0898US9456992B2Pharmaceutical composition comprising stable, amorphous, hybrid nanoparticles of at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix forming componentXSPRAY MICROPARTICLES AB·Filed 2013·Granted Oct 4, 2016·63 cites·55 claims
- 0997US11517562B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2022·Granted Dec 6, 2022·3 cites·30 claims
- 1097US11426391B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2022·Granted Aug 30, 2022·3 cites·30 claims
- 1197US11376243B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2022·Granted Jul 5, 2022·4 cites·30 claims
- 1297US10561643B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2019·Granted Feb 18, 2020·20 cites·27 claims
- 1397US10561645B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2019·Granted Feb 18, 2020·20 cites·18 claims
- 1497US10561644B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2019·Granted Feb 18, 2020·20 cites·29 claims
- 1597US10555937B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2019·Granted Feb 11, 2020·20 cites·29 claims
- 1697US10314829B2Pharmaceutical compositionsXSPRAY MICROPARTICLES AB·Filed 2018·Granted Jun 11, 2019·19 cites·30 claims
- 1793US12144804B1Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2024·Granted Nov 19, 2024·0 cites·30 claims
- 1893US2024398769A1Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2024·Application pending·0 cites
- 1991US12076314B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2024·Granted Sep 3, 2024·0 cites·30 claims
- 2091US8585942B2Process and arrangement for producing particles utilizing subcritical fluidsDEMIRBUEKER MUSTAFA·Filed 2008·Granted Nov 19, 2013·14 cites·20 claims
- 2190US8585943B2Method and arrangement for the production of particlesDEMIRBUEKER MUSTAFA·Filed 2008·Granted Nov 19, 2013·13 cites·17 claims
- 2286US7829123B2ProcessASTRAZENECA AB·Filed 2006·Granted Nov 9, 2010·7 cites·18 claims
- 2383US11963951B2Pharmaceutical compositionsXSPRAY PHARMA AB·Filed 2021·Granted Apr 23, 2024·0 cites·23 claims
- 2474US7108867B2Process for preparing particlesASTRAZENECA AB·Filed 2002·Granted Sep 19, 2006·7 cites·17 claims
- 2568US6461642B1Crystallization using supercritical or subcritical fluidsASTRAZENECA AB·Filed 1999·Granted Oct 8, 2002·26 cites·42 claims
- 2666US2016250153A1Novel methodsXSPRAY MICROPARTICLES AB·Filed 2016·Application pending·0 cites
- 2761US2014044819A1Method and Arrangement for the Production of ParticlesXSPRAY MICROPARTICLES AB·Filed 2013·Application pending·0 cites
- 2857US6475524B1Composition of matterASTRAZENECA AB·Filed 1999·Granted Nov 5, 2002·14 cites·26 claims
- 2951US2015231120A1Tiotropium preparationsCERBIOS PHARMA SA·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mustafa Demirbüker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →